Newest lipoglycopeptides for the management of acute bacterial skin and skin structure infections Article

Full Text via DOI: 10.1097/01.NPR.0000544995.21102.7f PMID: 30153191 Web of Science: 000444686200007

Cited authors

  • Bell, Allison M.; King, S. Travis; Barber, Katie E.; Adcock, Kim G.; Wagner, Jamie L.; Stover, Kayla R.


  • Acute bacterial skin and skin structure infections (ABSSSIs) are some of the most commonly encountered infections worldwide. Hospitalizations as a result of ABSSSIs are associated with high mortality. This article discusses the role of oritavancin and dalbavancin, the two newest lipoglycopeptides, in the context of the other available I.V. infusion standard therapy options.

Publication date

  • 2018

Published in


International Standard Serial Number (ISSN)

  • 0361-1817

Start page

  • 31

End page

  • 37


  • 43


  • 10